GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $36,000 | -88.9% | 27,700 | -86.3% | 0.00% | – |
| Q1 2022 | $325,000 | -27.1% | 202,018 | -6.2% | 0.00% | -100.0% |
| Q4 2021 | $446,000 | +1043.6% | 215,400 | +2033.5% | 0.00% | – |
| Q3 2021 | $39,000 | -96.7% | 10,096 | -97.3% | 0.00% | -100.0% |
| Q2 2021 | $1,185,000 | +77.9% | 370,199 | +20.6% | 0.00% | 0.0% |
| Q1 2021 | $666,000 | +1802.9% | 307,000 | +1864.5% | 0.00% | – |
| Q4 2020 | $35,000 | -10.3% | 15,627 | -22.3% | 0.00% | – |
| Q1 2020 | $39,000 | -65.2% | 20,100 | -48.6% | 0.00% | – |
| Q4 2019 | $112,000 | -22.2% | 39,100 | +12.6% | 0.00% | – |
| Q2 2019 | $144,000 | -39.2% | 34,732 | -6.9% | 0.00% | – |
| Q2 2018 | $237,000 | – | 37,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Benchmark Capital Advisors | 221,700 | $1,051,000 | 0.83% |
| EAM Global Investors LLC | 227,063 | $1,076,000 | 0.56% |
| EAM Investors, LLC | 319,187 | $1,513,000 | 0.25% |
| COURAGE CAPITAL MANAGEMENT LLC | 30,000 | $142,000 | 0.11% |
| Cutter & CO Brokerage, Inc. | 53,600 | $254,000 | 0.10% |
| SABBY MANAGEMENT, LLC | 286,800 | $1,360,000 | 0.08% |
| D.A. DAVIDSON & CO. | 731,300 | $3,466,000 | 0.07% |
| Tibra Equities Europe Ltd | 63,414 | $301,000 | 0.05% |
| Advisor Group, Inc. | 556,377 | $2,637,000 | 0.04% |
| Laurel Wealth Advisors, Inc. | 21,400 | $101,000 | 0.03% |